ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $13,000 | -51.9% | 500 | 0.0% | 0.01% | -53.3% |
| Q4 2020 | $27,000 | +28.6% | 500 | 0.0% | 0.02% | +15.4% |
| Q3 2020 | $21,000 | -12.5% | 500 | 0.0% | 0.01% | -18.8% |
| Q2 2020 | $24,000 | +14.3% | 500 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $21,000 | 0.0% | 500 | 0.0% | 0.02% | +23.1% |
| Q4 2019 | $21,000 | +16.7% | 500 | 0.0% | 0.01% | +8.3% |
| Q3 2019 | $18,000 | +38.5% | 500 | 0.0% | 0.01% | +33.3% |
| Q2 2019 | $13,000 | 0.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $13,000 | +62.5% | 500 | 0.0% | 0.01% | +28.6% |
| Q4 2018 | $8,000 | -20.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $10,000 | +25.0% | 500 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $8,000 | -27.3% | 500 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $11,000 | -26.7% | 500 | 0.0% | 0.01% | -20.0% |
| Q4 2017 | $15,000 | -21.1% | 500 | 0.0% | 0.01% | -23.1% |
| Q3 2017 | $19,000 | +35.7% | 500 | 0.0% | 0.01% | +30.0% |
| Q2 2017 | $14,000 | -17.6% | 500 | -0.2% | 0.01% | -16.7% |
| Q1 2017 | $17,000 | +21.4% | 501 | +0.2% | 0.01% | +20.0% |
| Q4 2016 | $14,000 | -12.5% | 500 | 0.0% | 0.01% | -16.7% |
| Q3 2016 | $16,000 | 0.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $16,000 | +14.3% | 500 | 0.0% | 0.01% | +9.1% |
| Q1 2016 | $14,000 | -22.2% | 500 | 0.0% | 0.01% | -26.7% |
| Q4 2015 | $18,000 | +5.9% | 500 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $17,000 | -19.0% | 500 | 0.0% | 0.02% | -11.8% |
| Q2 2015 | $21,000 | +31.2% | 500 | 0.0% | 0.02% | +30.8% |
| Q1 2015 | $16,000 | 0.0% | 500 | 0.0% | 0.01% | -7.1% |
| Q4 2014 | $16,000 | +33.3% | 500 | 0.0% | 0.01% | +27.3% |
| Q3 2014 | $12,000 | +9.1% | 500 | 0.0% | 0.01% | +22.2% |
| Q2 2014 | $11,000 | -8.3% | 500 | 0.0% | 0.01% | -18.2% |
| Q1 2014 | $12,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |